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Abstract.  Microtubule-associated proteins (MAPs) are 
believed to play an important role in regulating the 
growth of neuronal processes.  The nerve growth fac- 
tor-induced differentiation of PC12 pheochromocytoma 
cells is a  widely used tissue culture model for study- 
ing this mechanism. We have found that contrary to 
previous suggestions, the major MAPs of adult brain, 
MAP1  and MAP2, are minor components of PC12 
cells. Instead two novel MAPs characteristic of de- 
veloping brain,  MAP3 and MAP5, are present and in- 
crease more than  10-fold after nerve growth factor 
treatment; the timing of these increases coinciding 
with the bundling of microtubules and neurite out- 
growth. Immunocytochemical staining showed that 
MAP3 and MAP5 are initially distributed throughout 
the cytoplasm. Subsequently MAP5 becomes as- 
sociated with microtubules in both neurites and growth 
cones but MAP3 distribution remained diffuse. Thus 
MAP3 and MAP5, which are characteristic of de- 
veloping neurons in the juvenile brain, are also in- 
duced in PC12 cells during neurite outgrowth in cul- 
ture.  In contrast MAP1, which is characteristic of 
mature neurons, does not increase during PC12 cell 
differentiation. These results provide evidence that one 
set of MAPs is expressed during neurite outgrowth 
and a different set during the maintenance of neuronal 
form. It also appears that the PC12  system is an ap- 
propriate model for studying the active neurite growth 
phase of neuronal differentiation but not for neuronal 
maturation. 
T 
HE assembly of microtubules is an essential step in 
the growth of neuronal processes (6,  35, 41), and it 
is therefore important to identify those components of 
the neuronal cytoplasm that modulate tubulin polymeriza- 
tion.  Much  recent  work  has  focused  on  microtubule- 
associated proteins (MAPs) ~  because they stimulate tubulin 
polymerization in vitro and are particularly abundant in the 
brain (5, 8, 23, 31, 39).  Some of these proteins are particu- 
larly  associated  with  neuronal  processes.  For  example 
MAP2 is concentrated in dendrites (30) and tau MAPs are 
concentrated in axons (2).  Several of the MAPs are also im- 
plicated in neuronal differentiation because large changes in 
their content in brain coincide with the completion of axon 
and dendrite growth (1, 9, 27, 33, 34).  The sequential induc- 
tion of different MAPs  might thus be correlated with the 
different steps in neurite initiation, extension, and stabiliza- 
tion (28,  32). 
Many recent studies of neurite outgrowth have used the 
PC12 rat pheochromocytoma cell line (12), which can be in- 
duced to form axon-like processes by treatment with nerve 
growth factor (NGF; 4, 7, 13, 14, 16, 20, 25). Several lines of 
evidence suggest that MAPs play an important part in the 
1.  Abbreviations used in  this paper:  MAPs,  microtubule-associated pro. 
teins;  NGF,  nerve growth factor. 
molecular mechanism of neurite outgrowth in PC12 cells (4, 
7,  14). Drubin et al. (7) have shown that changes in tubulin 
levels in PC12 cells exposed to NGF do not parallel the de- 
gree of microtubule polymerization activity in the cell. They 
proposed instead that it is biochemical changes in MAPs, 
which are induced by NGF, that are primarily responsible for 
the formation of microtubules and for microtubule bundling, 
and that therefore MAPs regulate the formation of neurites. 
Other studies have shown that microtubules in NGF-treated 
cells are more stable to the tubulin-depolymerizing drugs 
and low temperatures than are microtubules in cells grown 
without NGF (3, 21, 22). It has been suggested that MAPs, 
synthesized in response to NGF, confer this stability. 
The exact identity of the MAP components involved in 
neurite formation has yet to be settled. It is known that the 
relative amounts of  both a high molecular mass MAP species 
and  the  tau  MAPs  in  PC12  cells  increase  dramatically 
(10-20-fold) after long-term NGF-treatment (14). However, 
NGF also induces changes in the phosphorylation state of the 
chartins (4), a recently discovered group of MAPs similar 
in size to, but chemically distinct from tau MAPs (26), and 
it is unclear what the relative importance of tau and the char- 
tins are.  The situation with respect to the high molecular 
mass MAPs is even more uncertain. Using a sensitive immu- 
noassay, Black et al.  (4)  detected increased MAP2  levels 
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Drubin et al.  (7)  tentatively identified the high molecular 
mass NGF-induced MAP of PC12 cells as MAPI and Greene 
et al. (14) termed it MAP1.2. However, there are several high 
molecular mass MAP components that migrate on SDS- 
polyacrylamide gels above MAP2, in the region of MAP1, 
and it is not clear which of these was studied in these experi- 
ments. The protein in this size range that we describe in rela- 
tion to PC12 differentiation in this paper is a novel MAP, 
(MAP5) that is not closely related to MAP1 and that we have 
characterized in detail elsewhere (34,  36, 37). 
The exact identification of NGF-induced MAPs is an es- 
sential prerequisite for determining their role in PC12 cell 
neurite outgrowth. In this study we have used mAbs against 
MAPI, MAP2, MAP3, and MAP5, which are MAPs that are 
well-characterized in brain microtubules (1,  17,  18, 29) and 
have been found to undergo large changes during postnatal 
brain development (33, 34). We document changes in the rel- 
ative amounts of these MAPs during the differentiation of 
PC12 cells and demonstrate that the one that undergoes the 
largest  change  in  expression,  MAP5,  also  undergoes  a 
significant change in its cytoplasmic distribution. Our results 
indicate  parallels  between  MAP  synthesis  in  the  NGF- 
induced outgrowth of PC12  cells and early events during 
brain morphogenesis in terms of MAP induction. 
Materials and Methods 
Cell Culture 
PCI2 cells were grown in DME (Gibco, Renfrewshire, Scotland) containing 
5% heat-inactivated FCS and 10% horse serum. Cells exposed to NGF (100 
ng/ml) were grown in the same medium supplemented with 1% horse se- 
rum. For exposure to NGF, cells were plated at 2  ×  104 cells/cm  2 on poly- 
styrene tissue culture dishes coated with 100 p.g/ml collagen R (Serva Bio- 
chemicals, Heidelberg, Federal Republic of Germany). 
Microtubule Preparation 
Cells were washed twice with PBS, harvested in 1.5 vol of diluted (1:1,000) 
microtubule assembly buffer (0.1 M 2-[N-morpholino] ethanesuifonic acid, 
pH 6.4, containing 2 mM EGTA, and  1 mM MgCi2  without GTP) sup- 
plemented with phenylmethylsulphonyl fluoride (PMSF), pepstatin A, and 
antipain, each at 10 p.M to inhibit proteolysis during preparation. The cells 
were disrupted with a teflon pestle tissue grinder. One-tenth volume of 10x 
microtubule assembly buffer was added to the homogenate and after 10 min 
at 4°C, the homogenate was centrifuged at 180,000 g for 90 min in an Air- 
fuge (Beckman Instruments, Geneva, Switzerland). Microtubule formation 
was induced by the addition of  taxol (National Institute of  Cancer, Bethesda, 
Maryland) to 20 p.M, and GTP to 1 mM. The microtubules were harvested 
by centrifugation for 15 min at 180,000 g (40). The pellet was dissolved in 
SDS-containing sample buffer and the proteins were separated by elec- 
trophoresis in a 3-14% polyacrylamide gel (24).  Proteins were blotted on 
nitrocellulose and immunoperoxidase-stained with antibodies as described 
by Towhin et al. (38). Anti-MAP1 (17), anti-MAP2 (17), anti-MAP3 (18), 
and  anti-MAP5  (34)  were  used  as  previously  described.  Monoclonal 
anti-[~-tubulin was obtained from Dr. L. I. Binder (University of Alabama). 
All mAbs were used as a  1:20 dilution of the hybridoma supernatant. 
Immunodot Assay 
Cell homogenate was centrifuged at 180,000 g for 90 rain at 4°C and the 
supernatant  fractions (3.5  mg/ml)  were  immobilized as 0.5  I.tl dots on 
nitrocellulose. Changes in the relative amount of each MAP during NGF- 
induced ceil differentiation were determined by scanning the anti-MAP 
immunoperoxidase-stained dots of superuatant proteins and measuring the 
peak height for each dot using a Shimadzu reflectance densitometer (Bur- 
kard Instruments, Zurich, Switzerland). A twofold dilution series of the su- 
peruatant proteins was made to establish that the measurements made with 
each antibody lay in the linear range of the logarithmic relationship between 
densitometric peak height of the immunoperoxidase-stained sample and the 
amount of  antigenic protein attached to the nitrocellulose (15), Series of dots 
from each time point were stained with Amido black and scanned to verify 
that equal amounts of protein were dotted onto the nitrocellulose. None of 
the MAPs were detectable in the cold pellet, indicating that supernatant 
fractions are representative of total  PCI2 MAPs. 
lmrnunofluorescent Labeling of Cultured PC12 Cells 
Cells were plated at a density of 2  x  104 cells/cm  2 in 35-ram tissue culture 
dishes coated with R collagen (100 ~tg/ml). The cells were rinsed with 100 
mM PBS (150 mM NaCl, pH 7.2), fixed with 3% paraformaldehyde in PBS 
for 30 min at room temperature and then treated with 0.05%  Triton X-100 
in PBS for 10 rain to permeabilize the cell membrane. The fixed cells were 
treated with PBS containing 5% FCS for 10 rain to block nonspecific bind- 
ing and incubated with mAbs. All mAbs were used as a 1:50 dilution of the 
hybridoma supernatant. After incubation overnight, the cells were washed 
with PBS and incubated further with rhodamine-labeled goat anti-mouse 
immunoglobulin (DAKOPATTS, Copenhagen, Denmark) diluted 1:200 for 
2h. 
Results 
Changes in MAPs during PC12 Cell Differentiation 
To determine the MAP content and changes in the relative 
amounts of MAPs, equivalent amounts of taxol-precipitated 
PC12 microtubule protein from undifferentiated and differ- 
entiated (10-d NGF-treated) cells were loaded on SDS-gels, 
blotted onto nitrocellulose,  and immunostained for MAP 
proteins. 
Anti-MAP1 detected a minor protein band that comigrated 
with rat brain MAP1  (350 kD) in microtubules from both 
undifferentiated  and differentiated PC12 cells (Fig. 1). There 
were no detectable changes in the amount of MAP1 between 
NGF-treated and control cultures. Anti-MAP2 stained a very 
faint band with the same Mr as rat brain MAP2 (280 kD). 
10 d after NGF-induced differentiation there was approxi- 
mately a twofold increase in MAI>2 (Figs.  1 and 2).  Both 
MAP1  and MAP2 are present at very low levels  in PC12 
cells; to detect them at all we had to overload the gel by load- 
ing 20 Ixg/mm of protein compared with 5 ~g/mm for op- 
timal Coomassie Blue staining of whole PC12  proteins. 
In contrast, the anti-MAP3 gave strong staining of a pair 
of polypeptides whose size, Mr =  180 kD, was identical to 
that of MAP3 in adult rat brain microtubules. We observed 
a 10-fold increase in the level of this protein in NGF-treated 
PC12 cells compared to that in undifferentiated cells (Figs. 
1 and 2). However there was an even larger change in MAP5 
(320 kD,  similar to rat brain) that underwent a  15-fold in- 
crease during the 10 d of NGF treatment (Figs.  1 and 2). 
To determine the exact timing and the change in the rela- 
tive amounts of each MAP induced by NGE PC12 superna- 
tant protein was collected at daily intervals after NGF treat- 
ment  and  quantified by  immunodot assay.  The  levels  of 
MAP1, -2, -3, -5, and tubulin were measured in dilution se- 
ries of these supernatants using appropriate mAbs (Fig. 2). 
To be certain that we were measuring the appropriate pro- 
tein, the supernatant fractions from days 0,  1, 2, 3, 4, and 
10 were separated on an SDS-gel, blotted and stained with 
antibodies  specific  for  MAP3,  MAP5,  and  I~-tubulin 
(Fig. 3). 
The dot immunoassay (Fig. 2) and the supernatant immu- 
noblots (Fig. 3)  show clearly that both MAP3 and MAP5 
protein induction occurs after a lag phase of 2 d after NGF 
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after  10  d  NGF  (100 ng/rnl) treatment. 
Taxol-precipitated  PC12 microtubule  pro- 
teins  and  rat  brain  microtubule  proteins 
were loaded onto an SDS gel (20 I~g/mm 
slot) and transferred to nitrocellulose.  The 
nitrocellulose  was cut  into  strips  and  in- 
cubated with mAbs against MAP1, MAP2, 
MAP3, and MAP5. 
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Figure 2. Changes of the relative amount of MAPs and tubulin dur- 
ing PCI 2 differentiation. Equal amounts of PCI2 supernatant frac- 
tion protein after different periods of exposure to NGF were dotted 
in a  dilution  series  (twofold) on nitrocellulose  and  stained  with 
mAbs. Changes in the relative amount of each MAP and tubulin 
were determined by scanning the immunoperoxidase-stained  dots 
using a reflectance densitometer, e, MAP5; A, MAP3; B, MAP2; 
A, MAPI;  and o, tubulin. 
treatment, after which there was a  steady accumulation of 
both  MAPs.  In  contrast  to  MAP3  and  -5,  tubulin  levels 
changed by only twofold over the 10-d period of NGF treat- 
ment and there was no lag phase. MAP1 levels did not change 
detectably and  MAP2  showed about the  same twofold in- 
crease as tubulin (Fig.  2). 
lntracellular Distribution of  MAPs in PC12 Cells 
Undifferentiated PC12 cells have a round or polygonal cell- 
shape with short, thin cytoplasmic extensions (Figs. 4 a and 
5 a). These cells contain a dense microtubule network that 
spreads out to the border of the thin cytoplasmic extensions 
(Figs. 4  d  and 5 b).  The microtubules at this stage are not 
bundled and are characteristically "curly:  Undifferentiated 
cells stained with MAP5 (Fig. 4 g) and MAP3 mAbs (Fig. 
4  k)  show  a  strong  but  diffuse cytoplasmic staining.  The 
staining of the thin cytoplasmic extensions is not as strong 
as in the nuclear region, even allowing for the lesser cyto- 
plasmic volume in the cell periphery. 
After treatment with NGF for 1 h,  PC12 cells spread on 
the  substratum  and  grow  short,  flat processes  with  small 
growth cones (Figs.  4  b, and 5,  c  and d).  The majority of 
the cells remain at this state of differentiation until day 3. At 
this stage the microtubules are still not bundled (Figs. 4 e and 
5 c). MAP3 and MAP5 are still evenly distributed through- 
out the  cytoplasm of the cell body as well as  in the  short 
processes and growth cones, but do not present a  fibrillar 
staining pattern (Fig. 4, h  and i). This can be compared to 
the distribution  of tubulin,  which  is  arranged in  filaments 
(Fig.  4  e). 
Brugg and Matus MAP Induction  in PCI2 Cells  645 Figure 3. Induction of MAP3 and MAP5 in PC12 cells. Supernatant fraction protein from days 0,  1, 2, 3, 4, and 10 were loaded on an 
SDS gel (20 ~tg/mm slot), transferred to nitrocellulose, and immunostained. MAP3 and MAP5 induction occurs 2 d after NGF exposure 
in contrast to tubulin, which shows a linear increase from the beginning of NGF treatment. 
After day 3 of NGF treatment the PC12 cells undergo a 
transition to a neuron-like morphology. The cell body rounds 
up and the short processes generate growth cones (Fig. 5, g 
and h). The neurites start to grow very rapidly, and in cells 
maintained for 7 d with NGF, the microtubules are bundled 
in neurites and the fibrillar staining pattern seen earlier with 
tubulin antibody is only detectable in the cell body, the neu- 
rite branching region, and in the growth cones (Fig. 4 f). 
Throughout this  period of rapid  neurite growth  MAP3 
continues to be evenly distributed throughout the cytoplasm 
(Fig.  4,  k,  l,  and m).  However, we noticed a  decrease in 
MAP3 staining in growth cones (Fig. 4 m, arrow, and Fig. 
6, b and d) and a noticeable change from a diffuse cytosolic 
to a somewhat punctate distribution. 
MAP5, on the other hand, shows a distinct change in its re- 
lationship to microtubules. After being distributed through- 
out the cytoplasm on day 3, it becomes associated with mi- 
crotubules by day 7  (Fig. 7, b and d).  The tubulin and the 
MAP5 antibodies show the same staining pattern in neurites, 
neurite branching regions, and in the growth cones (Fig. 4, 
fand i). 
Anti-MAP1  stains the cells at all stages of differentiation 
very weakly and seems to be limited to the cell body. In con- 
trast, the MAP2 antibody staining is distributed over the en- 
tire differentiated cell, but this staining is also very faint and 
is not fibrillar. There is no staining with rhodamine-labeled 
second antibody alone (results not shown). 
Discussion 
The majority of the components that have been identified in 
brain microtubules (MAP1, MAP2, MAP3, MAP5, tan pro- 
teins, and chartins; 1, 2, 4, 7, 13, 18, 34) can also be detected 
in the PC12 cell line. This, and the fact that undifferentiated 
PC12 cells can be induced by NGF to differentiate into cells 
with typical neuronal morphology, makes this cell line an 
ideal model system to study the putative role of  MAPs in neu- 
ronal differentiation. 
Expression of  MAP3 and MAP5 Seems To Be a General 
Feature of  Early Neuronal Differentiation 
Our results suggest that there are significant parallels be- 
tween NGF-induced neurite outgrowth in  PC12  cells and 
The Journal of Cell Biology,  Volume 107, 1988  646 Figure 4. Microtubule arrangement and distribution of MAP5 and MAP3 in differentiating PCI2 ceils. In undifferentiated PC12  cells (a, 
d, g, and k) polymerized tubulin is distributed throughout the cell extending to the tip of the thin cytoplasmic extensions (d).  MAP5 (g) 
and MAP3 (k) show a diffuse distribution. Cells treated for 3 d with NGF (b, e, h, and 1) generate short processes. At this stage microtubules 
are still not bundled (e), and MAP5 (h) and MAP3 (l) remain cytosolic. After 7 d NGF treatment (c,f, i, and m), the cells produce long 
neurites with well-developed growth cones.  MAP5  (i) is colocalized with microtubules in growth cones (arrow)  and neurites (see also 
Fig. 6, c and d).  MAP3 staining (m) changes from a diffuse to a more punctate staining pattern and decreases in growth cones (arrow). 
Bar,  10 ~tm. 
early  events  during  the  morphogenesis  of brain  neurons. 
MAP3 and MAP5 are abundant in PC12 cells as they are in 
developing  rat brain  where  neurons  are  not  fully differen- 
tiated  (18,  34).  Even in undifferentiated  PC12  cells,  MAP3 
and MAP5 are readily detectable on immunoblots; immuno- 
cytochemical  staining  for MAP3  and  MAP5  is very bright 
and  diffuse  throughout  the  cytoplasm.  MAP5  in brain  ap- 
pears to be distributed throughout axons, dendrites,  and cell 
bodies of neurons that have just started to differentiate (34), 
and  anti-MAP3  stains  cell bodies and  the outgrowing  pro- 
cesses  in juvenile  brain  (28). 
During brain development MAP3  and MAP5  are "early" 
Brugg and Matus MAP Induction  in  PCI2 Cells  647 Figure 5. Bundling of microtubules during PC12 differentiation. Cells were fixed and stained with 13-tubulin antibody after different NGF 
exposure times (a and b, no NGF; c and d,  1 h; e and f, 3 d; g and h, 4 d). Until day 3, microtubules curl and twist as individual filaments, 
then they start to bundle and become visible as thick cords in neurites  (h, arrows). Bar, 10 Bm. 
MAPs,  that is MAPs that are present in neurons from the 
earliest phase of differentiation but  whose levels decrease 
when neurons reach their mature form (33). Soon after NGF 
induction  PC12  cells  generate  short processes  with  small 
growth cones and the  majority of the cells remain at this 
differentiation stage until day 3. During this time the MAP3 
and MAP5 pools remain at the same level as in uninduced 
PC12 cells. After day 3 the neurites begin to generate large 
growth cones and the rate of neurite extension increases rap- 
idly. This morphological change occurs simultaneously with 
a large increase in MAP3 and MAP5 levels in PC12 cells be- 
tween days 2  and  3.  The  MAP3  and  MAP5  levels subse- 
quently continue to increase, along with neurite length.  By 
10 d  after NGF inductiofi,  we could measure a  10-fold in- 
crease in MAP3 and a  15-fold increase in MAP5 compared 
with  undifferentiated  PC12  cells.  Thus  the  presence  of 
MAP3 and MAP5  in differentiating neurons seems to be a 
general feature of brain development, and PC12 cells repre- 
sent a culture system where these same proteins are induced 
during neurite outgrowth. 
In rat brain,  MAP3 and MAP5  levels drop dramatically 
after brain maturation (33,  34).  We did not observe a drop 
in MAP3 and MAP5  levels in PC12,  even after long-term 
NGF treatment.  Tucker and  Matus  (36)  have recently ob- 
served a decrease of MAP5 staining in developing avian reti- 
nal ganglion cells after the axons reached their target cells 
in the tectum. It thus seems possible that PC12 cells do not 
show a  similar decrease in MAP3 and MAP5 because the 
neurites remain in an outgrowth phase, never reaching a final 
differentiation stage because they cannot make synapses with 
target cells. 
MAP1 and MAP2 are Minor Proteins in PCI2 Cells 
Immunohistochemical  studies  in  rat  brain  with  the  same 
mAbs as were used here have shown that MAP1 is associated 
with neurons and is more abundant in dendrites than in axons 
(1). With  respect to brain  development,  MAP1  is  a  "late" 
MAP,  its levels increasing when dendrite growth is already 
well-advanced (28). In PC12 cells MAP1 could be detected 
as  a  very  minor  component  in  taxol-precipitated  PC12 
microtubules by immunoassay, but the results show clearly 
that MAPI is not induced during PC12 differentiation. Other 
workers have reported a large increase in levels of a high mo- 
lecular mass MAP species, referred to as either MAP1  (7) 
or MAP1.2, (14) after NGF-induced PC12 cells. Judging by 
our results using antibodies that distinguish between MAP1 
and the  similarly sized MAP5,  it seems probable that the 
high molecular mass MAP whose increase was observed in 
these earlier studies was MAP5 and not MAP1. 
MAP2 in brain is represented by two high molecular mass 
components, MAP2a and MAP2b, and a recently described 
70-kD component, MAP2c (10, 11). High molecular mass 
MAP2 is present in PC12 cells and shows an approximately 
The Journal of Cell Biology, Volume  107,  1988  648 Figure 6.  Distribution  of MAP3  in  growth  cones  during  PC12 
differentiation.  MAP3 staining decreases  in growth cones during 
differentiation (a and b, 3 d NGF; c and d, 7 d NGF) and never 
shows a fibrillar staining pattern as is seen with anti-tubulin (com- 
pare with Fig. 5 h).  Bar, 5 ~tm. 
Figure 7.  Distribution  of MAP5  in  growth  cones  during  PC12 
differentiation. After being distributed throughout the cytoplasm (a 
and b, 5 d NGF), MAP5 starts to be associated with microtubules 
between day 6 and 7 (c and d, 7 d NGF). It then shows the same 
fibrillar distribution as tubulin (compare with Fig. 5 h). Bar, 5 lam. 
twofold increase in taxol-precipitated PC12 microtubules af- 
ter 10 d exposure of PC12 cells to NGE These findings are 
in agreement with those of Black et al. (4) who also detected 
low amounts of MAP2 in differentiated PC12 cells using an 
immunoprecipitation assay. We could not detect MAP2c in 
PC12 even though this protein is characteristically expressed 
by neurons in the developing brain (29). 
Generally we can say that MAP1  and MAP2  are minor 
proteins in PC12 cells whose levels do not change greatly af- 
ter  long-term  treatment  with  NGE  Since  high  levels  of 
MAP1 are characteristic of mature neurons in the rat nervous 
system (28) this suggests further that NGF-treated PC12 cells 
remain in a state equivalent to early neuronal differentiation 
under these culture conditions. 
Association of  MAP5 with Microtubules 
Occurs Only after Exposure to NGF 
Tubulin  appears  as  filaments  at  all  stages  of  PC12  cell 
differentiation.  Until day 3,  single microtubules are visible 
even in the short flat processes that the cell generates.  The 
microtubules are not bundled at this stage, but rather curl and 
twist as individual filaments. Simultaneously with the onset 
of fast neurite outgrowth and the increase in levels of MAP3 
and MAP5, the microtubules become visible as thick cords 
in the neurites, which are known to correspond to microtu- 
bule bundles (20). Single, nonbundled microtubules can still 
be seen in growth cones and in the cell body. Anti-MAP3 
staining did not show a  filamentous staining pattern at any 
stage of PCI2 cell development, despite its strong binding to 
tubulin polymers in vitro (18) and its ability to promote tubu- 
lin assembly (19). It is thus unlikely to play a role in the reor- 
ganization of microtubules that occurs in the cytoplasm of 
PCI2  cells  during  neurite  induction.  MAP5  is  also  dis- 
tributed throughout the cytoplasm for the first 5 d after NGF 
treatment.  However, after day 6  anti-MAP5 gives filamen- 
tous staining in growth cones and neurites whose appearance 
is identical to that of anti-tubulin-stained filaments. Although 
we  were  unable  to  obtain  a  double-label  immunofluores- 
cence  demonstration  of identity  between  the  anti-tubulin 
Brugg and Matus MAP Induction  in PC12  Cells  649 stained  filaments  and  those  stained  by  anti-MAP5,  their 
similarity,  together with the fact that MAP5  in vitro binds 
strongly  to  microtubules  but  not  to  neurofilaments  (34), 
strongly suggest that after day 6 of NGF treatment MAP5 be- 
comes  bound  to  microtubules.  Thus  the  relationship  of 
MAP5  to microtubules changes during  the neurite elonga- 
tion  phase.  Although  there  is  no  obvious  morphological 
change coinciding with this event, Jacobs and Stevens (21) 
have shown that after 7 d of NGF treatment  PC12 neurites 
become more resistant  to microtubule depolymerization by 
nocodazole. In vitro, both MAP3 and MAP5 promote tubu- 
lin polymerization and coassemble with microtubules (18, 
34). However, these results make it evident that inside living 
PC12  cells the distribution  and  putative  function of these 
molecules  is  determined  by  factors  in  addition  to  their 
affinity for tubulin.  As the case of MAP5 shows, the balance 
between these factors may be modulated during differentia- 
tion so that the relationship of the molecule to the cytoskele- 
ton is changed. 
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